Clifton C. Mo, MD | Authors

Dana-Farber Cancer Institute

Boston, Massachusetts

Articles

Frontline Treatment Options for Multiple Myeloma

April 26, 2021

An expert hematologist-oncologist reviews the standard of care for transplant-eligible and transplant-ineligible patients with newly diagnosed MM and explores the role of quadruplet induction regimens.